|
J Biol Chem, Vol. 273, Issue 39, 25006-25014, September 25, 1998
Detection of a Conserved -Helix in the Kinase-docking Region
of the Aspartate Receptor by Cysteine and Disulfide Scanning*
Randal B.
Bass and
Joseph J.
Falke
From the Department of Chemistry and Biochemistry, University of
Colorado, Boulder, Colorado 80309-0215
 |
ABSTRACT |
The transmembrane aspartate receptor of
Escherichia coli and Salmonella typhimurium
propagates extracellular signals to the cytoplasm, where its
cytoplasmic domain regulates the histidine kinase, CheA. Different
signaling states of the cytoplasmic domain modulate the kinase
autophosphorylation rate over at least a 100-fold range. Biochemical
and genetic studies have implicated a specific region of the
cytoplasmic domain, termed the signaling subdomain, as the region that
transmits regulation from the receptor to the kinase. Here cysteine and
disulfide scanning are applied to the N-terminal half of the signaling
subdomain to probe its secondary structure, solvent exposure, and
protein-protein interactions. The chemical reactivities of the scanned
cysteines exhibit the characteristic periodicity of an -helix with
distinct solvent-exposed and buried faces. This helix, termed 7,
ranges approximately from residue 355 through 386. Activity
measurements probing the effects of cysteine substitutions in
vivo and in vitro reveal that both faces of helix
7 are critical for kinase activation, while the buried face is
especially critical for kinase down-regulation. Disulfide scanning of
the region suggests that helix 7 is not in direct contact with its
symmetric partner ( 7') from the other subunit; presently, the
structural element that packs against the buried face of the helix
remains unidentified. Finally, a novel approach termed "protein
interactions by cysteine modification" indicates that the exposed
C-terminal face of helix 7 provides an essential docking site for
the kinase CheA or for the coupling protein CheW.
 |
INTRODUCTION |
A fundamental question in signaling biology concerns the mechanism
by which cell surface receptors regulate cytoplasmic kinases. Certain
receptors activate their associated kinases by dimerization, but in
other cases kinase activation is triggered by a transmembrane conformational change. One class of receptors that generates such conformational regulation is the large group of cell surface receptors that modulate histidine kinases in prokaryotic and eukaryotic two-component signaling pathways (reviewed in Refs. 1-9). The aspartate receptor of bacterial chemotaxis is representative of this
diverse class. The aspartate receptor is one of the ligand specific
dimeric receptors utilized by the related chemotaxis pathways of
Escherichia coli and Salmonella typhimurium to
recognize periplasmic attractant and repellent molecules. This receptor binds aspartate, an attractant, in the periplasm and propagates a
signal across the bilayer to an associated histidine kinase in the
cytoplasm. Receptor-kinase coupling is provided by the formation of a
kinetically stable ternary complex between the cytoplasmic domain of
the receptor, the coupling protein CheW, and the histidine kinase CheA
(10, 11). The cytoplasmic phosphorylation cascade is initiated by
receptor-stimulated CheA autophosphorylation; subsequently,
phospho-CheA becomes the substrate for a phospho-transfer reaction that
phosphorylates one of two response regulator proteins, CheY or CheB
(12, 13). Phospho-CheY controls the swimming activity of the cell by
docking to the flagellar motor, while phospho-CheB regulates the
adaptation branch of the chemotaxis pathway by hydrolyzing the methyl
esters of specific glutamates that serve as receptor adaptation sites
(14-17). The level of receptor-mediated CheA kinase activation or
down-regulation is determined by the sum of the signals generated by
ligand binding to the receptor in the periplasm, and the level of
receptor methylation in the cytoplasm (12, 13). Since aspartate binding
down-regulates the kinase activity while receptor methylation
stimulates the kinase, the two signals oppose each other to provide a
negative feedback loop that optimizes the signal output of the ternary complex (2).
The bacterial chemoreceptors, including the aspartate receptor, belong
to the taxis receptor subfamily of the two-component receptor
superfamily. The taxis receptor subfamily spans at least 60 known
homologues proposed to initiate the thermo-, photo-, osmo-, redox-, and
chemotaxis pathways of a wide variety of prokaryotic organisms
(18-25). The primary structures of subfamily members diverge greatly
in their periplasmic domains, which are specific for different stimuli;
however, their cytoplasmic domains are highly conserved (18, 19). These
receptors also possess a conserved mechanism of transmembrane signaling
and kinase regulation, as demonstrated by the formation of active
chimeric receptors via the fusion of receptor domains from distantly
related pathways (26-29). Moreover, an active chimera has been
generated by fusing the transmembrane signaling domain of the aspartate
receptor and the tyrosine kinase domain of the human insulin receptor,
indicating that even these unrelated receptors may use similar
mechanisms of conformational transmembrane kinase regulation (30,
31).
The periplasmic and transmembrane regions of the aspartate receptor are
structurally well characterized. The receptor is a homodimer of two
stably associated 60-kDa subunits (32). A high resolution crystal
structure of the isolated periplasmic domain has revealed a dimer of
two four-helix bundles ( 1- 4 and 1'- 4'), where the
symmetric helices 1 and 1' form a tightly associated coiled coil
at the dimer interface (1). The structure of the transmembrane region
has been characterized by disulfide mapping and consists of a bundle of
the four membrane-spanning helices 1/TM1, 1'/TM1', 4/TM2, and
4'/TM2' (33-42). The mechanism of transmembrane signaling is a
subtle piston-type displacement of the signaling helix 4/TM2 toward
the cytoplasm, as observed in the superimposed crystal structures of
the apo- and aspartate-occupied periplasmic domain (43). Further
evidence for the piston displacement is provided by engineered
disulfide bonds that lock the membrane-bound receptor in the on and off
states, by ligand-induced changes in disulfide formation rates detected
in a closely related receptor for ribose and galactose, and, most
recently, by spin-labeled ESR measurements (34, 39, 43-45).
Until recently, comparatively little structural information has been
available for the cytoplasmic domain of the receptor, because its
unusually dynamic conformation has prevented analysis by high
resolution methods (46). Earlier hydrodynamic studies indicated that
the cytoplasmic domain is highly elongated, while circular dichroism
studies revealed a high degree of -helicity (47, 48). The
cytoplasmic domain is functionally critical, because it contains the
adaptive methylation sites and the docking sites for the kinase CheA
and coupling protein CheW in the active ternary complex. Once formed,
the ternary complex containing the receptor, CheW, and CheA, is stable
for tens of minutes, regardless of the receptor ligand occupancy and
methylation state (10, 11). The adaptive methylation sites are
glutamate side chains located at positions 295, 302, 309, and 491 within the cytoplasmic domain (49). These residues are
methyl-esterified by the methyltransferase CheR, which binds to a
specific site at the receptor C terminus, and are demethylated by
phospho-CheB (50-52). The signaling subdomain, extending approximately
from residue 348 through 427, lies between the third and fourth
methylation sites (18, 19). This subdomain appears to constitute an
independent folding unit that binds CheW and CheA and modulates the
rate of CheA autophosphorylation (53-56).
Recent cysteine and disulfide scanning studies have revealed helices
4, 5, and 6 as well as structured linkers between these
helices within the cytoplasmic domain (57-59). Helices 5 and 6
were determined by disulfide mapping to be at the dimer interface.
Helix 6 contains three of the four sites of adaptive methylation at
positions 295, 302, and 309. However, despite its functional
significance, the structure of the signaling subdomain remains unknown.
Genetic studies have shown that this subdomain contains the site(s) of
interaction with the coupling protein CheW, and biochemical studies
have implicated it as a major locus of CheA interactions as well
(53-55, 60). Finally, the signaling subdomain of a related receptor
has been shown to be unusually susceptible to mutations that lock the
swimming behavior of cells (61). Given these observations, the
signaling subdomain is a prime target for structural studies designed
to characterize the mechanism by which a receptor-mediated
transmembrane signal is translated by the cytoplasmic domain into
kinase regulation.
Cysteine and disulfide scanning has proven to be an invaluable tool for
the determination of protein structure and has the advantage of not
being limited by the size of the macromolecule to be studied (33-35,
41, 42, 44, 62, 63). This technique has been successfully employed in
previous structural and mechanistic studies of the bacterial
chemoreceptors that revealed the aforementioned helices 4- 6 of
the cytoplasmic domain (57, 58). The present study extends the cysteine
and disulfide scanning approach to the N-terminal half of the signaling
domain, where the goal is to elucidate the secondary structure,
packing, and function of the region. The results reveal an -helix
with distinct exposed and buried faces. Both of these faces are
critical for kinase activation, while the buried face is particularly
critical for kinase down-regulation. The exposed face near the C
terminus of the helix is found to provide a docking site for CheW,
CheA, or both, as revealed by the protein interactions by cysteine
modification (PICM)1
method.
 |
EXPERIMENTAL PROCEDURES |
Materials--
The E. coli strains utilized were kindly
provided by Dr. John S. Parkinson (University of Utah, Salt Lake City,
UT). Strains used for receptor expression and characterization were
RP3808 ( (cheA-cheZ)DE2209 tsr-1 leuB6 his-4 eda-50 rpsL136
[thi-1 (gal-attl)DE99 ara-14 lacY1 mtl-1 xyl-5 tonA31
tsx-78]/mks/) and RP8611( /CP362 of G. Hazelbauer via F. Dahlquist, pa/) (64). The receptor expression plasmid pSCF6 has
been previously described (33). Expression strains and plasmids used to
produce CheA (HB101/pMO4), CheW (HB101/pME5), and CheR (JM109/pME43)
were generously provided by Dr. Jeff Stock (Princeton University,
Princeton, NJ). The strain and plasmid used to generate CheY,
(RBB455/pRBB40), were kindly provided by Dr. Bob Bourret (University of
North Carolina, Chapel Hill, NC). Chemical reactivity probes, 5-IAF,
5-FM, and IANBD were obtained from Molecular Probes, Inc. (Eugene, OR).
S-Adenosyl-L-[methyl-3H]methionine
and [ -32P]ATP were purchased from Amersham Pharmacia
Biotech. Deoxyoligonucleotides were synthesized by Life Technologies,
Inc. Kunkel mutagenesis reagents (T7 DNA polymerase, T4 DNA ligase, and
deoxynucleotide triphosphates) were purchased from Bio-Rad. Unless
specifically noted, all other reagents were obtained from Sigma and
were reagent grade.
Creation of Cysteine-containing Receptors--
Individual
cysteine-containing receptors were created by oligonucleotide-directed
mutagenesis of the plasmid pSCF6 by the method of Kunkel et
al. as modified by the Bio-Rad phagemid mutagenesis kit (33, 65).
Mutagenesis reactions were transformed into RP8611, and plasmids were
isolated using Qiagen spin columns. Receptor genes encoding the
appropriate cysteine substitution were verified by PCR plasmid
sequencing using a modification of the Sanger method employing a
thermocycler and reagents from Epicentre Technologies (66).
Purification of Engineered Receptors--
Plasmids encoding
individual cysteine substitutions were transformed into the strain
RP3808 (64). Receptors were purified as described previously (57) with
the following modifications. 18 h after inoculation with saturated
2-ml Luria broth cultures, 500-ml Vogel-Bonner citrate minimal media
cultures (67) were harvested by centrifugation in a GS-3 rotor
(Sorvall) at 6000 rpm (6080 × g) for 10 min. Cells
were resuspended in 6 ml of ice-cold low salt buffer containing 20 mM sodium phosphate, pH 7.0, with NaOH, 10% (v/v)
glycerol, 10 mM EDTA, 50 mM DTT, 2.5 mM 1,10-phenanthroline, and 0.5 mM
phenylmethylsulfonyl fluoride in thin walled ultracentrifuge tubes
(Beckman) in an ice/salt water bath and lysed by sonication (3 × 20-s bursts with 20-s cooling intervals using a Mysonics model W-385
sonicator equipped with a macrotip). Cell debris was pelleted in a TLA
100.3 rotor (Beckman) at 15,000 rpm (12,000 × g) for
20 min. Supernatants were transferred to fresh tubes, and membranes
were pelleted in a TLA100.3 rotor at 100,000 rpm (540,000 × g) for 15 min. Pellets were resuspended in 0.5 ml of high
salt buffer, 20 mM sodium phosphate, pH 7.0, with NaOH, 2 M KCl, 10% (v/v) glycerol, 10 mM EDTA, 5 mM DTT, 2.5 mM 1,10-phenanthroline, and 0.5 mM phenylmethylsulfonyl fluoride. Resuspension was achieved by placing tubes in an ice/salt water bath and sonicating with the
aforementioned sonicator equipped with a microtip (2 × 20-s bursts and 20-s cooling intervals). Membranes were diluted to 3 ml in
high salt buffer, pelleted again, and resuspended as above, except DTT
and phenanthroline were omitted. Finally, receptor-containing membranes
were resuspended in 0.5 ml of final buffer containing 20 mM
sodium phosphate, pH 7.0, with NaOH, 10% (v/v) glycerol, 0.1 mM EDTA, and 0.5 mM phenylmethylsulfonyl
fluoride before diluting to 3 ml in final buffer, pelleting as above,
and resuspending in 300 µl of final buffer. The resulting membranes
were snap frozen in liquid nitrogen and stored at 80 °C.
Protein samples were assayed for total protein using the BCA assay
(Pierce) calibrated against bovine serum albumin standards (Pierce).
After development, absorbance measurements were made using a microplate
reader (Molecular Devices, Inc.). Protein purity was determined by
quantitating the receptor and nonreceptor bands on a Coomassie-stained
10% Laemmli SDS-polyacrylamide gel (acrylamide:bisacrylamide ratio of
40:0.2) using a digital camera (Alpha Innotec) (68).
Preparation of Cytoplasmic Chemotaxis Components--
CheA, CheW,
CheY, and CheR were produced and isolated as described previously (33,
57).
Chemical Reactivity Assays--
Reactivity assays were performed
as described previously (58) with the following modifications. All
quantitation was performed using a digital camera (Alpha Innotec).
Alkylation of each engineered receptor was performed with 5-IAF except
in the case of the periplasmic control positions Thr95
through His103, where both 5-IAF and IANBD were used as
labels. Reaction conditions were essentially as described previously
(58). Briefly, the assay utilized a 40-µl reaction containing 5 µM receptor monomer in reaction buffer (10 mM
sodium phosphate, pH 6.5, with NaOH, 50 mM NaCl, 50 mM KCl, and 10 mM EDTA), to which was added 300 µM 5-IAF in DMF. The reaction was allowed to proceed at
25 °C for 5 min. At that point, the reaction mixture was split, and half of the sample was quenched with 1.25 µl of -mercaptoethanol to react with any remaining probe. The remainder of the sample was
denatured with 0.6% (w/v) SDS at 95 °C, allowed to react for an
additional 3 min, and then quenched as before. To each reaction was
added 5 µl of 4× nonreducing Laemmli sample buffer, and then each
was heated to 95 °C for 2 min prior to resolving on a 10% Laemmli
SDS-polyacrylamide gel (acrylamide:bisacrylamide ratio of 40:0.2).
Fluorescent receptor bands were visualized on a UV light box (Alpha
Innotec) and quantitated with a digital camera (Alpha Innotec). Gels
were subsequently stained with Coomassie, and the resulting receptor
bands were quantitated with a digital camera to provide normalization
of the fluorescent intensities for variations in the amount of
receptor. Chemical reactivity was defined as the ratio of receptor
alkylation in the folded versus the unfolded states.
In Vivo Activity Assays--
Chemotaxis swarm assays were
performed in vivo as described previously (57, 69). Controls
using vector alone (pBluescript) and vector carrying the wild type
receptor (pSCF6) were performed to determine the swarm rates of
receptorless cells and cells possessing the native receptor,
respectively. All swarm rates were determined on minimal media agar
plates lacking or containing 100 µM aspartate. The
aspartate-specific swarm rates were determined by subtracting the minus
aspartate swarm rate from the plus aspartate swarm rate to correct for
pseudotaxis (53), and the resulting rate was then normalized to the
wild type rate for comparison.
In Vitro Activity Assays--
The in vitro
receptor-coupled kinase assay was performed essentially as described
with the following modifications (12, 13, 57). Standard membranes
containing the reduced receptor were utilized except in experiments
testing the effects of engineered disulfide bonds (see below). The
receptor-coupled kinase reaction was initiated by the addition of
[ -32P]ATP to the reaction mixture containing receptor,
CheW, CheA, and excess CheY. After 10 s, aliquots were removed and
quenched with 2× Laemmli sample buffer supplemented with 25 mM EDTA. The concentration of proteins used in the standard
assay ensures that receptor-regulated CheA autophosphorylation is the
rate-determining step, such that the rate of phosphotransfer to CheY is
linearly proportional to the CheA autophosphorylation rate.
32P-Phosphorylated CheY was resolved on a 15% Laemmli
SDS-polyacrylamide gel (acrylamide:bisacrylamide ratio of 40:1.25).
Gels were dried and quantitated by PhosphorImager analysis (Molecular
Dynamics, Inc.). In a 10-µl wild type reaction mixture containing 60 pmol of receptor monomer, 20 pmol of CheW, 100 pmol of CheY, 2.6 pmol of CheA, and 1000 pmol of ATP and reaction buffer (50 mM
Tris, pH 7.5, with HCl, 50 mM KCl, and 5 mM
MgCl2), phospho-CheY was produced at a rate of 0.02 pmol
s 1.
In some assays the engineered cysteines were oxidized to form an
intersubunit disulfide bond in order to test the effect of this
cross-link on receptor-mediated kinase regulation (33, 34). Briefly,
membrane samples containing 12 µM receptor monomer were
incubated with 0.2 mM
Cu(II)(1,10-phenanthroline)3 and ambient O2
(approximately 200 µM) for 20 min at 37 °C. This
oxidation was inactivated by the addition of 0.1 mM sodium
persulfate, and the resulting membranes were used in the
receptor-coupled kinase assay as above. The extent of disulfide
formation was determined by analyzing an aliquot of the oxidized
membranes on a 10% nonreducing Laemmli SDS-polyacrylamide gel
(acrylamide:bisacrylamide ratio of 40:0.2). Gels were subsequently
Coomassie-stained, monomer and dimer bands were quantitated with a
digital camera, and the percentage of dimer formation was
calculated.
Disulfide Formation Rates--
Each full-length, membrane-bound
cysteine-containing receptor was diluted to a final concentration of
approximately 2 µM in 20 mM sodium phosphate,
pH 7.0, with NaOH, 10% (v/v) glycerol, 5 mM EDTA. The
oxidation reaction was initiated by the addition of 1 mM
Cu(II)(1,10 phenanthroline)3 (59). The reaction was allowed
to proceed for 10 s at 25 °C and then quenched with 2× Laemmli
sample buffer supplemented with 2 mM NaAs04,
0.2 mM EDTA, and 10 mM
N-ethylmaleimide (33, 34, 59, 68). Samples were resolved on
a 10% Laemmli SDS-polyacrylamide gel as in the chemical reactivity
assay and Coomassie-stained, and the monomer and dimer bands were
quantitated with a digital camera.
PICM--
For each engineered receptor, a 15-µl reaction mixture
containing 12 µM membrane-bound receptor monomer was
mixed with either 150 µM 5-FM in DMF (final
concentration) or, in the case of a control, 0.5 µl of DMF. The
modification reaction was allowed to proceed at 25 °C for 1 min and
then quenched with 35 mM DTT. These reaction tubes were
held on ice until used just as in the in vitro
receptor-coupled kinase assay as described above. As before, the
membrane samples were incubated with CheA, CheW, and CheY in reaction
buffer, followed by the addition of radiolabeled ATP, and the
phosphotransfer reactions were allowed to proceed for 10 s before
quenching. The resulting phospho-CheY bands were visualized and
quantitated by PhosphorImager analysis.
As a control to determine whether the 5-FM labeling proceeded to
completion, control reactions were performed as in the chemical reactivity assay. A 40-µl reaction mixture prepared containing 5 µM receptor monomer was mixed with 125 µM
5-FM in DMF (final concentration). The reaction was allowed to proceed,
as before, for 1 min at 25 °C; half of the sample was quenched with
50 mM DTT; and the remainder of the sample was denatured in
0.6% SDS at 95 °C and allowed to react for an additional 3 min
before quenching. The latter sample served as a control for maximum
label incorporation. The extent of labeling was determined by
quantitating the fluorescence in the receptor band using a digital
camera.
In Vitro Methylation Assays--
Receptor-containing membranes
were first diluted to make an 11-µl stock of 10 µM
receptor monomer. After labeling with 125 µM 5-FM in DMF
and quenching (see above), the methylation reaction was carried out
largely as described (70). Briefly, to the above sample was added 1 µl of CheR-containing cytosolic extract (15-20 mg/ml total protein)
and potassium phosphate (pH 7.0 with NaOH) to 40 mM. The
reactions were then allowed to equilibrate for at least 30 min at
25 °C to allow the receptor-CheR complex to form. The methylation
reaction was initiated by the addition of a 1:1 ratio of 2 mM S-adenosyl-L-methionine to
S-adenosyl-L-[methyl-3H]methionine
(55-85 Ci/mmol, 1 µCi/µl), to achieve a final
S-adenosyl-L-methionine concentration of 0.1 mM. Aliquots of the reaction were removed at 50, 60, and
70 s, spotted on 1 × 1-cm Whatman filter papers, and
immediately placed in a rapidly stirring 10% (w/v) trichloroacetic acid bath for 10 min at 25 °C. The trichloroacetic acid wash was repeated twice, followed by washing in methanol for 2 min to remove residual trichloroacetic acid. The methanol wash was repeated, and
filter papers were allowed to air dry for 5 min. Individual filter
papers were placed in 0.65-ml Eppendorf tubes and then floated in 4 ml
of Ecoscint H (National Diagnostics) in a scintillation vial. To the
filter paper was added 100 µl of 1 M NaOH to hydrolyze the methyl esters, and the scintillation vials were capped. Liberated methanol partitioned into the scintillation mixture during an 18-h
incubation at 37 °C, at which point the vials were
scintillation-counted.
Standard Deviation--
The error ranges given represent the S.D.
for n 3.
 |
RESULTS |
Creation of Cysteine Library--
To probe the signaling region of
the cytoplasmic domain, a library of mutant receptors was created by
cysteine scanning. Using oligonucleotide-directed mutagenesis to create
a unique cysteine substitution in each receptor, the position of
substitution was scanned from Thr348 through
Ala387, representing approximately the N-terminal half of
the signaling subdomain. Fig. 1 presents
a schematic diagram of the receptor structure, illustrating the
location of the scanned positions. Each engineered receptor was
generated via plasmid overexpression in an E. coli strain
that lacks receptors and the methylation and demethylation enzymes CheR
and CheB, respectively (RP3808) (64). As a result, the expressed
receptor population is homogenous with respect to the modification
states of the four cytoplasmic methylation sites (Gln295,
Glu302, Gln309, and Glu491).
Altogether, 40 single cysteine-containing receptors were generated, 37 of which were expressed at or near wild type levels. The remaining three mutant receptors, A353C, N374C, and E383C did not accumulate at
detectable levels in the membrane; thus, the native side chains at
these positions are critical for receptor expression, folding, or
stability.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
A schematic model of the full-length
membrane-bound aspartate receptor, illustrating the various domains and
subdomains. Cylinders represent helices determined by
previous studies employing crystallography (1) and cysteine and
disulfide scanning (33-36, 41, 42, 57, 58). The two 60-kDa subunits of
the homodimer are depicted in white and gray,
respectively. Filled circles represent the sites
of adaptive methylation on each subunit (49). The open
box denotes the region of the signaling subdomain probed by
cysteine and disulfide scanning in the current study (residues
Thr348 through Ala387).
|
|
The Chemical Reactivity Assay--
Previous studies have
demonstrated that the solvent-exposure pattern displayed by a library
of scanned cysteines can map out surface-exposed secondary structure
elements (57, 58). In the present study, the solvent exposure of each
engineered cysteine was determined by assaying its chemical reactivity
with 5-IAF, a large anionic sulfhydryl-specific probe. The charge and
size of this aqueous probe virtually exclude it from the cores of
proteins so that it reacts slowly with buried cysteines and rapidly
with solvent-exposed cysteines.
To carry out the chemical reactivity assay, isolated E. coli
membranes containing a given receptor were incubated with the 5-IAF
probe at 25 °C for 5 min. Following this incubation, which was
designed to yield less than 50% full labeling at the majority of
cysteine positions, one half of the sample was quenched. The remaining
half was denatured with SDS at 95 °C and allowed to react for an
additional 3 min to ensure full labeling. Finally, both samples were
run on a SDS-polyacrylamide gel, and the receptor fluorescence was
quantitated with a digital camera. The ratio of fluorescence in the
native to the denatured states yielded the chemical reactivity, which
ranged from a value of 1 for a highly solvent-exposed sulfhydryl to a
value of 0 for a fully buried sulfhydryl.
The ability of the chemical reactivity assay to detect the periodic
fluctuation of solvent exposure due to local secondary structure
elements was tested by a control study of helix 2, which lies within
the known structure of the periplasmic domain. Using a library of
receptors in which cysteine was scanned from positions
Thr95 through His103 in helix 2, the
measured chemical reactivity ratio was found to be highly correlated
with the solvent exposure calculated from the crystal structure
coordinates of the periplasmic domain as illustrated in Fig.
2 (1, 71). Both the anionic probe 5-IAF and the neutral probe IANBD yielded similar results (Fig. 2), indicating that the chemical reactivity ratio is determined mainly by
solvent exposure, rather than by interactions of the probe with local
electrostatic fields.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of measured chemical reactivities
and calculated solvent exposure in a known -helix. Cysteine
scanning was used to place a cysteine residue at positions 95-103 of
helix 2 in the known structure of the periplasmic domain. Each
cysteine-containing receptor was incubated with a sulfhydryl-specific
probe, either 5-IAF (open circles) or IANBD (open
squares) for 5 min at 25 °C. Subsequently, half the reaction
was quenched with excess BME, while the other half was denatured with
heat and SDS to allow full labeling before quenching. The chemical
reactivity parameter is defined as the ratio of receptor labeling in
the native sample to the denatured sample, followed by normalization to
the highest reactivity observed for each probe. The solvent exposure of
the -carbon at each position, indicated by the filled
circles, was calculated from the crystal structure of the
periplasmic domain (1) by the method of Richards (71).
|
|
Chemical Reactivities of Scanned Cysteines in the Cytoplasmic
Domain--
The measured chemical reactivity ratios for the scanned
cysteines T348C through A387C within the signaling subdomain are
summarized in Fig. 3. This figure also
illustrates the reactivity levels used to operationally define highly
buried, intermediate, and highly exposed cysteines. Eight cysteines
were determined to be highly buried, yielding a native:denatured
reactivity ratio of below 15% (S355C, S356C, I362C, I363C, T373C,
N379C, A380C, and N386C). Nine positions were highly exposed,
displaying reactivities greater than 35% (M349C, K357C, V365C, D367C,
G368C, F371C, I375C, A381C, and A385C). When these positions were
mapped onto different secondary structure models, it was found that the
best segregation of highly buried and exposed residues occurs on an
-helix (see Fig. 7A). Thus, the results indicate the
presence of an -helix with distinct buried and exposed faces
spanning approximately positions 355-386 in the signaling subdomain.
No significant ligand-induced change in the reactivity was found for
any position in this region (data not shown), indicating that no
radical rearrangement of this region is triggered by ligand binding to
the full-length, membrane-bound receptor under these assay
conditions.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Chemical reactivities of residues T348C
through A387C in the signaling subdomain. Using 5-IAF as the
probe, the chemical reactivity of each cysteine-containing receptor in
isolated E. coli membranes was measured as described in the
legend to Fig. 2. Positions with a reactivity of below 0.15, indicated
by the lower dashed line, are defined
as highly buried. Positions exhibiting a reactivity above 0.35, indicated by the upper dashed line,
are classified as solvent-exposed.
|
|
Effects of Cysteine Substitutions on in Vivo Receptor
Function--
Positions critical for function in vivo were
found by assaying the ability of the engineered receptors to mediate
chemotaxis. Each wild type or engineered receptor was generated by
plasmid overexpression in an E. coli strain that lacks
functional aspartate and serine chemoreceptors (RP8611) (64). The
ability of an engineered receptor to restore chemotactic swarming up an
aspartate gradient in semisolid agar directly measured the functional
effect of its engineered cysteine (69). This assay is designed to
detect only the most deleterious cysteine substitutions, since subtle
receptor defects are corrected by receptor overexpression or by
receptor adaptation via methylation (33, 34). Inhibitory substitutions were defined as those that reduced the aspartate-specific swarm rate at
least 2-fold relative to the wild type receptor. Fig. 4 summarizes the observed relative,
aspartate-specific swarm rates as well as the operational definition of
inhibitory and noninhibitory substitutions. The 24 inhibitory
substitutions were found to lie on both the buried and exposed faces of
the helix identified by chemical reactivity measurements (see Fig.
7B), indicating that both faces of the helix are critical
for function. One cysteine substitution, A360C, was found to mediate a
swarm rate 3-fold faster than wild type, revealing that the native
receptor is not fully optimized for aspartate-specific chemotaxis in
the standard chemotaxis assay. Overall, the data illustrate an
extremely high density of critical contacts in the signaling subdomain
relative to other regions of the cytoplasmic domain examined in
previous studies (see "Discussion").

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
In vivo activity of the engineered
cysteine-containing receptors. Engineered receptors were expressed
in an E. coli strain lacking the aspartate receptor, and the
ability of each receptor to restore chemotaxis up an aspartate gradient
was measured by the swarm assay (33, 69). The aspartate-specific swarm
rate represents the difference between the chemotactic swarm rates
measured on minimal media plates containing and lacking aspartate,
respectively. In addition, the indicated rate differences have been
normalized to the corresponding difference observed for cells
expressing the wild type receptor. Receptors yielding rates
below the dashed line (50% of wild
type) are classified as inhibitory.
|
|
Effects of Cysteine Substitutions on in Vitro Receptor
Function--
Additional activity measurements were carried out using
an in vitro assay designed to detect more subtle
perturbations of receptor-mediated kinase regulation (12, 13).
Reconstitution of the active ternary signaling complex was achieved by
adding highly purified coupling protein CheW and the histidine kinase CheA to isolated E. coli membranes containing the receptor
of interest. Activity of the reconstituted complex was assayed by observing the rate of phosphotransfer to a saturating concentration of
the response regulator CheY. Under these conditions, the
autophosphorylation of CheA is the rate-limiting step. The maximal
autophosphorylation rate is stimulated by the apo receptor, while
aspartate binding to the complex slows autophosphorylation over
100-fold.
Fig. 5 illustrates that in the absence of
attractant, 21 of the 37 engineered receptors retained the ability to
stimulate CheA autophosphorylation to at least 20% of the wild type
level. In seven of these receptors, however, the cysteine substitution prevented the normal ligand-induced down-regulation of CheA
autophosphorylation (E351C, S356C, K358C, I363C, I369C, A377C, and
A387C). Each of these substitutions yielded retention of at least 15%
of the maximal native autophosphorylation rate even in the presence of
1 mM aspartate. This partial inhibition of ligand-induced
down-regulation was not due to a loss of aspartate binding, since each
of these engineered receptors exhibited the characteristic increase in
the methylation rate seen in the in vitro receptor
methylation assay upon the addition of ligand (data not shown). Thus,
these seven cysteine substitutions are termed "lock-on" cysteines,
because they prevent full conversion of the receptors from the on state
to the off state upon aspartate binding. Interestingly, all of the
lock-on cysteines were found on the buried face of the helix identified by chemical reactivity measurements, representing the highest density
of lock-on cysteines yet observed in the cytoplasmic domain (see
"Discussion"). It follows that the buried helix contacts play a
critical role in kinase down-regulation.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
In vitro activity of the engineered
receptors. Isolated E. coli membranes containing a
given receptor were mixed with purified cytoplasmic components to
reconstitute the receptor-CheW-CheA ternary complex and its
phosphorylation target, CheY (12, 13, 33). [32P]ATP was
added to initiate the phosphorylation cascade, and the reaction was
quenched after 10 s. The resulting [32P]phospho-CheY
was quantitated and used to determine the rate of phospho-CheY
production, which was finally normalized to the wild type rate.
Closed circles indicate rates observed in the absence of
aspartate, wherein the apo receptor activates kinase activity. Apo
receptors that yield rates below the lower
dashed line (20% of the wild type rate) are
defined as inhibitory, while rates above the
upper dashed line (200% of the wild
type rate) are denoted superactivated. Open circles and
thick lines indicate the rates measured in the
presence of saturating aspartate. Under these conditions, the wild type
rate is diminished to undetectable levels. Filled
triangles denote lock-on cysteine positions at which the
cysteine substitution prevents full aspartate-triggered kinase
down-regulation.
|
|
The remaining 16 cysteine substitutions yielded at least 90%
inhibition of receptor-mediated kinase activation in the absence of
attractant, indicating that the on state of the receptor was significantly perturbed. Unlike the lock-on cysteines, the 16 inhibitory cysteines were found on both the exposed and buried faces of
the newly identified helix (see Fig. 7B) It follows that both faces of the helix are essential to kinase activation.
Disulfide Formation and Extents--
Since each engineered
receptor possesses a pair of cysteines located at symmetric positions
in the two subunits of the homodimer, cysteines at the subunit
interface can be identified by their rapid rate of disulfide formation
and in certain cases by their minimal effect on receptor activity (2,
33, 34). Mild oxidation of cysteine pairs to disulfides was initiated
by the addition of the catalyst
Cu(II)(1,10-phenanthroline)3 to purified
receptor-containing E. coli membranes in the presence of a
Cu(II) buffer, EDTA (59). For cysteine pairs located within the
signaling subdomain, the maximal extent of disulfide formation was 30%
under mild oxidation conditions. Significantly, no cysteine pairs
approached the level of 60% disulfide formation achieved under
identical conditions for interfacial cysteines in the previously
identified 5 and 6 helices (57, 58). These results suggest that
the newly identified helix does not lie at the subunit interface.
Strong oxidation conditions were able to drive all cysteines in the
signaling domain to over 60% disulfide formation, enabling analysis of
the affect of each disulfide on kinase regulation in the in
vitro assay. In general, the intersubunit disulfide bonds formed
between symmetric cysteines in the signaling domain were found to block
kinase activation, yielding at least 100-fold inhibition of
autophosphorylation relative to the oxidized wild type receptor. Only
one disulfide generated in the scanned region, between
Cys387 and Cys387', was found to retain both
kinase activation and aspartate regulation. Table
I shows that when the
Cys387-Cys387' disulfide bond was driven to
over 90% completion, the disulfide-containing receptor maintained over
40% of the wild type kinase activation and yielded native
aspartate-induced down-regulation. The signal-retaining Cys387-Cys387' disulfide was formed between the
two subunits in the same dimer, rather than between colliding dimers,
since a double cysteine mutant, N36C/A387C, yielded disulfide-linked
dimers rather than oligomers upon oxidation (data not shown). In the
latter experiment, the dimer containing both the
Cys36-Cys36' and
Cys387-Cys387' disulfide bonds was identified
by its characteristic mobility on SDS-polyacrylamide gel
electrophoresis, in between the two control dimers that contain the
Cys36-Cys36' or
Cys387-Cys387' cross-link alone. Overall, the
failure of most intersubunit disulfides to retain kinase activation
provides additional evidence that the bulk of the scanned region does
not lie at the subunit interface. The C-terminal end of the scanned
region, however, may lie nearby the subunit interface, thereby enabling
the signal-retaining behavior of the
Cys387-Cys387' disulfide.
PICM--
In order to identify positions that contact CheA or the
coupling protein CheW, seven mutant receptors that possessed a
surface-exposed cysteine within the signaling subdomain and that
retained function in vitro were selected (H350C, D354C,
K357C, A360C, S364C, A381C, and A385C). These seven receptors were
labeled with 5-FM, a sulfhydryl-specific probe, and then tested for the
effect of probe attachment on receptor function in the in
vitro kinase regulation assay. Covalent modification with a large
probe at a CheW or CheA docking position was predicted to block
activation of CheA autophosphorylation. This approach is termed
PICM.
The results demonstrate the usefulness of PICM as a tool to map out a
functionally significant docking surface. The stoichiometry of labeling
was quantitated as in the solvent exposure assay and was found to range
from 0.8 to 1.0 probe molecule/receptor monomer, indicating that each
mutant cysteine was essentially fully labeled. Fig.
6 shows that four of the labeled
receptors, H350C, D354C, K357C, and A360C, maintained at least 50% of
the unlabeled kinase activation and full aspartate-triggered
down-regulation. A fifth labeled cysteine, S364C, maintained only 25%
of the unlabeled kinase activation but full aspartate down-regulation.
Labeling at the remaining two positions, A381C and A385C, blocked
kinase activation at least 90%, suggesting that these positions lie
within the CheA or CheW docking surface.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
The effects of covalent modification at
specific surface positions on kinase activation in
vitro. The indicated receptors in isolated E. coli membranes were modified with the cysteine-specific probe 5-FM
or unmodified, respectively. The in vitro activities of the
resulting receptors were measured in the receptor-coupled kinase assay
(see legend to Fig. 5). The resulting rates of phospho-CheY formation
observed in the absence of aspartate are indicated for each unmodified
(filled bars) and modified (open bars)
receptor.
|
|
An alternative explanation, namely that these inhibitory labels simply
disrupt the overall conformation or stability of the cytoplasmic
domain, was disfavored by the observation that the 5-FM labeled S364C,
A381C, and A385C receptors all retained wild type or better methylation
rates in the in vitro methylation assay (data not shown).
Since this assay is highly sensitive to perturbations of the
cytoplasmic domain conformation, the simplest explanation for the
observed kinase inhibition is that the covalent label causes a local
steric or electrostatic perturbation of the CheA or CheW docking
surface (33, 72). Interestingly, when the labeled cysteines are
arranged in order of sequence, there is a nearly perfect monotonic loss
of kinase activation when moving from the N-terminal to the C-terminal
positions (Fig. 6), suggesting that the C-terminal end of the scanned
region has the most intimate interactions with CheA or CheW.
 |
DISCUSSION |
The present study has employed cysteine scanning to probe the
secondary structure, packing, and function of residues
Thr348 through Ala387 in the cytoplasmic domain
of the aspartate receptor, corresponding to the N-terminal region of
the signaling subdomain. The measured chemical reactivities of the
scanned positions reveal a pattern of highly buried and exposed
residues beginning at approximately position Ser355 and
continuing without detectable breaks through Arg386. The
periodicity is consistent with that of an -helix, termed 7, as
shown in Fig. 7A. The best
segregation of highly buried and exposed residues is observed for a
helical model with 3.5 rather than 3.6 residues per turn, suggesting
that the observed helix has the heptad repeating pattern of a coiled
coil (Fig. 7A). An alignment of homologous receptors reveals
that the same heptad repeat is a conserved feature of the scanned
region, providing strong evidence that the observed coiled-coil helix
is a conserved structural element in this large receptor class (18,
19). Helix 7 is partially amphiphilic, since its charged residues fall predominantly on its exposed face. Other charges, such as Lys358 and Arg386, lie at the edge of the
observed packing surface while Glu383 lies less than one
turn from the predicted helix C terminus. The long side chains of the
residues could enable their charges to reach the solvent or to form
charge pairs (for example between Glu383 and
Arg386). Significantly, the a and d
positions of the conserved heptad repeat possess no charges and exhibit
the highest frequency of hydrophobic residues (Fig. 7A),
consistent with the conclusion that these positions lie on a conserved
packing face.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Helical wheel model for positions
Ser355 through Arg386 of the signaling
subdomains illustrating the measured chemical reactivities and activity
effects of the scanned cysteines. A, white
rectangles denote positions with high chemical reactivities
indicating solvent exposure; black rectangles indicate
buried positions yielding low chemical reactivities. The face of the
helix found to be largely buried is enclosed by the large
box, and residues likely to be charged are noted. Positions in
parentheses indicate cysteine substitutions that prevent
receptor accumulation in the membrane. B, black
ovals highlight lock-on cysteine substitutions that prevent full
aspartate-induced kinase down-regulation in the in vitro
kinase assay. Small open circles or
squares denote cysteine substitutions that retain receptor
function in the in vivo chemotaxis swarm assay or in the
in vitro receptor-coupled kinase assay, respectively.
Small closed circles or squares
represent cysteine substitutions that inhibit the ability of the
receptor to stimulate activity in the swarm assay or receptor-coupled
kinase assay, respectively. Large open
ovals denote positions that were implicated in CheW docking
by genetic studies (60).
|
|
The docking partner that packs against the buried face of helix 7
has not yet been identified. Helix 7 does not appear to intimately
pack against its symmetric partner to form an 7- 7' interaction at
the dimer interface, since 7- 7' intersubunit disulfides are
formed inefficiently and block receptor-mediated kinase activation. In
contrast, the previously characterized helices 5 and 6 exhibit
efficient intersubunit disulfide formation, and, in some cases, these
disulfides retain kinase activation (57, 58). The C terminus of helix
7 may lie near the subunit interface, thereby enabling the
Cys387-Cys387' intersubunit disulfide to form
and retain a significant level of kinase activation and regulation. No
evidence for an aspartate-induced displacement of the helix 7
packing face has been observed, since no aspartate-induced change in
cysteine labeling rates or 7- 7' disulfide formation rates has
been observed. This insensitivity to aspartate suggests that the
signal-induced rearrangement of the signaling subdomain is small
(consistent with the subtle conformational shift observed in the
periplasmic domain (1, 43)); alternatively, a larger rearrangement of
the subdomain could occur in the full ternary complex.
Activity measurements for the library of cysteine-containing receptors,
carried out both in vitro and in vivo, underscore the functional importance of helix 7. Of the 37 cysteine-containing receptors that accumulate to wild type levels in the membrane, 65% are
unable to mediate chemotaxis in vivo, while 43% were unable to activate CheA autophosphorylation in vitro. This is the
highest density of inhibitory cysteine substitutions yet observed in
the scanned regions of the cytoplasmic domain, where previous studies have yielded an average inhibition frequency of 34% in vivo
and 30% in vitro (57, 58). Another unusual feature of helix
7 is the sensitivity of its solvent-exposed face to perturbations by
cysteines; 29% of the inhibitory cysteines observed in vivo and 40% observed in vitro fall on the exposed face of the
helix. In contrast, previous in vivo and in vitro
studies of other regions of the cytoplasmic domain revealed that only 6 and 11%, respectively, of the inhibitory cysteines were located on
exposed helical faces (57, 58). Together, these results suggest that
unlike other regions of the cytoplasmic domain, both the exposed and
buried faces of the helix 7 are extensively involved in critical
contacts necessary for receptor-mediated kinase activation. In
particular, the in vitro receptor-coupled kinase assay
results demonstrate that cysteines on both helix faces can block
receptor stimulation of CheA autophosphorylation. Interestingly, the
lock-on cysteine substitutions that prevent full aspartate-induced
down-regulation of kinase activity in vitro were observed
only on the buried face of helix 7, suggesting that this face plays
the central role in attractant-induced kinase inhibition.
It is not surprising that the buried face of helix 7 is critical for
both kinase activation and down-regulation, since cysteine substitutions that perturb helix packing may inhibit the critical function of the signaling subdomain. However, one may ask why the
exposed face of helix 7 is so essential for kinase activation. PICM
analysis of the exposed cysteines, in which a large probe (5-FM) is
covalently attached to a series of surface-exposed cysteines, reveals
that modification of three positions near the C-terminal end of the
helix inhibits kinase activation in vitro. The inhibition is
not due to simple perturbation of cytoplasmic structure, since the
inhibitory chemical modifications do not significantly reduce the rate
of receptor methylation in the in vitro adaptation assay. Instead, the PICM results begin to map out a docking surface on the
exposed face of helix 7. The simplest interpretation is that CheA,
CheW, or both must dock to this exposed face to form the functional
ternary complex, in which the apo receptor is known to activate CheA
autophosphorylation.
Further support for the identification of helix 7 as a CheA or CheW
docking element is provided by sequence analysis and genetic data.
First, exposed positions in helix 7 are 100% identical between the
aspartate receptors of S. typhimurium and E. coli, whose chemotaxis pathways share functionally interchangeable
CheA and CheW (2). In contrast, much lower sequence conservation is
observed for the exposed faces of the previously characterized helices
4, 5, and 6 where exactly half of the exposed residues are
identical (18, 19, 57, 58). The highly conserved nature of the exposed
surface of helix 7 is consistent with its proposed role in CheA or
CheW docking. Second, exactly half of the residues on the exposed face
of helix 7 are hydrophobic (Fig. 7A), a much higher
frequency than observed on the exposed faces of helix 5 and 6 (0 and 16%, respectively). Such exposed hydrophobic residues, which are
among the most highly conserved residues in the scanned subdomain,
could facilitate intermolecular docking via the hydrophobic effect.
Third, genetic studies have previously implicated involvement of the
signaling subdomain in CheW docking. Within the scanned region, the
inhibitory effect of mutations at three receptor positions could be
overcome by compensatory mutations in CheW (60). Strikingly, all
three of these receptor positions lie on the newly identified exposed
face of helix 7 (Fig. 8), suggesting
that this face directly contacts the CheW molecule.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 8.
Model of the signaling domain illustrating
helix 7 and the results of the PICM study. Cylinders
represent experimentally determined helices 6 and 7 (57).
Ovals are shown for other regions of unknown secondary
structure, which are connected by loops. Small
squares indicate the positions examined in the PICM study.
Open squares indicate cysteine positions at which 5-FM
attachment maintains at least 50% of the kinase activation observed
for the unlabeled receptor. The gray and black
squares denote positions at which 5-FM labeling maintains less
than 25 or 10% of the relative kinase activation, respectively.
|
|
Together, these findings underscore the importance of helix 7 in
kinase docking activation and regulation. The results also provide
further illustrations of the usefulness of cysteine and disulfide
scanning in studies defining secondary structure and molecular packing
faces in proteins inaccessible to high resolution structural methods,
including transmembrane receptors. The current work also has expanded
this battery of applications to include the mapping of intermolecular
protein-protein interaction surfaces via PICM analysis. Currently, it
appears that these cysteine and disulfide engineering approaches may
yield the first chemically defined, low resolution structure of an
independently folded protein domain.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM40731 (to J. J. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 303-492-3503;
Fax: 303-492-5894; E-mail: falke{at}colorado.edu.
The abbreviations used are:
PICM, protein
interactions by cysteine modification; DTT, dithiothreitol; 5-IAF, 5-iodoacetamidofluorescein; 5-FM fluorescein-5-maleimide, IANBD,
N-((2-iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazoleDMF, N,N-dimethylformamide.
 |
REFERENCES |
-
Milburn, M. V.,
Prive, G. G.,
Milligan, D. L.,
Scott, W. G.,
Yeh, J.,
Jancarik, J.,
Koshland, D. E., Jr.,
and Kim, S. H.
(1991)
Science
254,
1342-1347[Abstract/Free Full Text]
-
Falke, J. J.,
Bass, R. B.,
Butler, S. L.,
Chervitz, S. A.,
and Danielson, M. A.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
457-512[CrossRef][Medline]
[Order article via Infotrieve]
-
Wurgler-Murphy, S. M.,
and Saito, H.
(1997)
Trends Biochem. Sci.
22,
172-176[CrossRef][Medline]
[Order article via Infotrieve]
-
Stock, J. B.,
and Surette, M. G.
(1996)
in
Escherichia coli and Salmonella Cellular and Molecular Biology (Neidhardt, F. C., ed), pp. 1103-1129, American Society for Microbiology Press, Washington, D. C.
-
Stock, A. M.,
and Mowbray, S. L.
(1995)
Curr. Opin. Struct. Biol.
5,
744-751[CrossRef][Medline]
[Order article via Infotrieve]
-
Blair, D. F.
(1995)
Annu. Rev. Microbiol.
49,
489-522[CrossRef][Medline]
[Order article via Infotrieve]
-
Swanson, R. V.,
and Simon, M. I.
(1994)
Curr. Biol.
4,
234-237[CrossRef][Medline]
[Order article via Infotrieve]
-
Bray, D.,
Bourret, R. B.,
and Simon, M. I.
(1993)
Mol. Biol. Cell
4,
469-482[Abstract]
-
Parkinson, J. S.
(1993)
Cell
73,
857-871[CrossRef][Medline]
[Order article via Infotrieve]
-
Gegner, J. A.,
Graham, D. R.,
Roth, A. F.,
and Dahlquist, F. W.
(1992)
Cell
70,
975-982[CrossRef][Medline]
[Order article via Infotrieve]
-
Schuster, S. C.,
Swanson, R. V.,
Alex, L. A.,
Bourret, R. B.,
and Simon, M. I.
(1993)
Nature
365,
343-347[CrossRef][Medline]
[Order article via Infotrieve]
-
Borkovich, K. A.,
Kaplan, N.,
Hess, J. F.,
and Simon, M. I.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
1208-1212[Abstract/Free Full Text]
-
Ninfa, E. G.,
Stock, A. M.,
Mowbray, S. L.,
and Stock, J. B.
(1991)
J. Biol. Chem.
266,
9764-9770[Abstract/Free Full Text]
-
Barak, R.,
and Eisenbach, M.
(1992)
Biochemistry
31,
1821-1826[CrossRef][Medline]
[Order article via Infotrieve]
-
Kehry, M. R.,
Doak, T. G.,
and Dahlquist, F. W.
(1985)
J. Bacteriol.
163,
983-990[Abstract/Free Full Text]
-
Russell, C. B.,
Stewart, R. C.,
and Dahlquist, F. W.
(1989)
J. Bacteriol.
171,
3609-3618[Abstract/Free Full Text]
-
Hess, J. F.,
Oosawa, K.,
Kaplan, N.,
and Simon, M. I.
(1988)
Cell
53,
79-87[CrossRef][Medline]
[Order article via Infotrieve]
-
Danielson, M. A.
(1997)
The Molecular Mechanism of Transmembrane Signaling and Kinase Regulation by the Aspartate Receptor of Bacterial ChemotaxisPh.D. thesis, University of Colorado, Boulder, CO
-
Le Moual, H.,
and Koshland, D. E., Jr.
(1996)
J. Mol. Biol.
261,
568-585[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhulin, I. B.,
Johnson, M. S.,
and Taylor, B. L.
(1997)
Biosci. Rep.
17,
335-342[CrossRef][Medline]
[Order article via Infotrieve]
-
Sundberg, S. A.,
Bogomolni, R. A.,
and Spudich, J. L.
(1985)
J. Bacteriol.
164,
282-287[Abstract/Free Full Text]
-
Egger, L. A.,
Park, H.,
and Inouye, M.
(1997)
Genes Cells
2,
167-184[Abstract]
-
Nara, T.,
Kawagishi, I.,
Nishiyama, S.,
Homma, M.,
and Imae, Y.
(1996)
J. Biol. Chem.
271,
17932-17936[Abstract/Free Full Text]
-
Iwama, T.,
Homma, M.,
and Kawagishi, I.
(1997)
J. Biol. Chem.
272,
13810-13815[Abstract/Free Full Text]
-
Nishiyama, S.,
Nara, T.,
Homma, M.,
Imae, Y.,
and Kawagishi, I.
(1997)
J. Bacteriol.
179,
6573-6580[Abstract/Free Full Text]
-
Baumgartner, J. W.,
Kim, C.,
Brissette, R. E.,
Inouye, M.,
Park, C.,
and Hazelbauer, G. L.
(1994)
J. Bacteriol.
176,
1157-1163[Abstract/Free Full Text]
-
Krikos, A.,
Conley, M. P.,
Boyd, A.,
Berg, H. C.,
and Simon, M. I.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
1326-1330[Abstract/Free Full Text]
-
Utsumi, R.,
Brissette, R. E.,
Rampersaud, A.,
Forst, S. A.,
Oosawa, K.,
and Inouye, M.
(1989)
Science
245,
1246-1249[Abstract/Free Full Text]
-
Tatsuno, I.,
Lee, L.,
Kawagishi, I.,
Homma, M.,
and Imae, Y.
(1994)
Mol. Microbiol.
14,
755-762[CrossRef][Medline]
[Order article via Infotrieve]
-
Biemann, H.-P.,
Harmer, S. L.,
and Koshland, D. E., Jr.
(1996)
J. Biol. Chem.
271,
27927-27930[Abstract/Free Full Text]
-
Moe, G. R.,
Bollag, E.,
and Koshland, D. E., Jr.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
5683-5687[Abstract/Free Full Text]
-
Milligan, D. L.,
and Koshland, D. E., Jr.
(1988)
J. Biol. Chem.
263,
6268-6275[Abstract/Free Full Text]
-
Chervitz, S. A.,
Lin, C. M.,
and Falke, J. J.
(1995)
Biochemistry
34,
9722-9733[CrossRef][Medline]
[Order article via Infotrieve]
-
Chervitz, S. A.,
and Falke, J. J.
(1995)
J. Biol. Chem.
270,
24043-24053[Abstract/Free Full Text]
-
Falke, J. J.,
and Koshland, D. E., Jr.
(1987)
Science
237,
1596-1600[Abstract/Free Full Text]
-
Pakula, A. A.,
and Simon, M. I.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4144-4148[Abstract/Free Full Text]
-
Lee, G. F.,
Burrows, G. G.,
Lebert, M. R.,
Dutton, D. P.,
and Hazelbauer, G. L.
(1994)
J. Biol. Chem.
269,
29920-29927[Abstract/Free Full Text]
-
Lee, G. F.,
Dutton, D. P.,
and Hazelbauer, G. L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5416-5420[Abstract/Free Full Text]
-
Hughson, A. G.,
and Hazelbauer, G. L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11546-11551[Abstract/Free Full Text]
-
Maruyama, I. N.,
Mikawa, Y. G.,
and Maruyama, H. I.
(1995)
J. Mol. Biol.
253,
530-546[CrossRef][Medline]
[Order article via Infotrieve]
-
Falke, J. J.,
Sternberg, D. W.,
and Koshland, D. E., Jr.
(1986)
Biophys. J.
49,
20-25
-
Falke, J. J.,
Dernburg, A. F.,
Sternburg, D. A.,
Zalkin, N.,
Milligan, D. L.,
and Koshland, D. E. J.
(1988)
J. Biol. Chem.
263,
14850-14858[Abstract/Free Full Text]
-
Chervitz, S. A.,
and Falke, J. J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2545-2550[Abstract/Free Full Text]
-
Hughson, A. G.,
Lee, G. F.,
and Hazelbauer, G. L.
(1997)
Protein Sci.
6,
315-322[Medline]
[Order article via Infotrieve]
-
Ottemann, K. M.,
Thorgeirsson, T. E.,
Kolodziej, A. F.,
Shin, Y. K.,
and Koshland, D. E., Jr.
(1998)
Biochemistry
37,
7062-7069[CrossRef][Medline]
[Order article via Infotrieve]
-
Seeley, S. K.,
Weis, R. M.,
and Thompson, L. K.
(1996)
Biochemistry
35,
5199-5206[CrossRef][Medline]
[Order article via Infotrieve]
-
Long, D. G.,
and Weis, R. M.
(1992)
Biochemistry
31,
9904-9911[CrossRef][Medline]
[Order article via Infotrieve]
-
Mowbray, S. L.,
Foster, D. L.,
and Koshland, D. E., Jr.
(1985)
J. Biol. Chem.
260,
11711-11718[Abstract/Free Full Text]
-
Terwilliger, T. C.,
and Koshland, D. E., Jr.
(1984)
J. Biol. Chem.
259,
7719-7725[Abstract/Free Full Text]
-
Lupas, A.,
and Stock, J. B.
(1989)
J. Biol. Chem.
264,
17337-17342[Abstract/Free Full Text]
-
Wu, J.,
Li, J.,
Li, G.,
Long, D. G.,
and Weis, R. M.
(1996)
Biochemistry
35,
4984-4993[CrossRef][Medline]
[Order article via Infotrieve]
-
Okumura, H.,
Nishiyama, S.,
Sasaki, A.,
Homma, M.,
and Kawagishi, I.
(1998)
J. Bacteriol.
180,
1862-1868[Abstract/Free Full Text]
-
Ames, P., Yu, Y. A.,
and Parkinson, J. S.
(1996)
Mol. Microbiol.
19,
737-746[CrossRef][Medline]
[Order article via Infotrieve]
-
Ames, P.,
and Parkinson, J. S.
(1994)
J. Bacteriol.
176,
6340-6348[Abstract/Free Full Text]
-
Surette, M. G.,
and Stock, J. B.
(1996)
J. Biol. Chem.
271,
17966-17973[Abstract/Free Full Text]
-
Surette, M. G.,
Levit, M.,
Liu, Y.,
Lukat, G.,
Ninfa, E. G.,
Ninfa, A.,
and Stock, J. B.
(1996)
J. Biol. Chem.
271,
939-945[Abstract/Free Full Text]
-
Danielson, M. A.,
Bass, R. B.,
and Falke, J. J.
(1997)
J. Biol. Chem.
272,
32878-32888[Abstract/Free Full Text]
-
Butler, S. L.,
and Falke, J. J.
(1998)
Biochemistry
37,
10746-10756[CrossRef][Medline]
[Order article via Infotrieve]
-
Chen, X.,
and Koshland, D. E., Jr.
(1997)
Biochemistry
36,
11858-11864[CrossRef][Medline]
[Order article via Infotrieve]
-
Liu, J. D.,
and Parkinson, J. S.
(1991)
J. Bacteriol.
173,
4941-4951[Abstract/Free Full Text]
-
Ames, P.,
and Parkinson, J. S.
(1988)
Cell
55,
817-826[CrossRef][Medline]
[Order article via Infotrieve]
-
Akabas, M. H.,
Stauffer, D. A.,
Xu, M.,
and Karlin, A.
(1992)
Science
258,
307-310[Abstract/Free Full Text]
-
Frillingos, S.,
Sun, J.,
Gonzalez, A.,
and Kaback, H. R.
(1997)
Biochemistry
36,
269-273[CrossRef][Medline]
[Order article via Infotrieve]
-
Liu, J. D.,
and Parkinson, J. S.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8703-8707[Abstract/Free Full Text]
-
Kunkel, T. A.,
Bebenek, K.,
and McClary, J.
(1991)
Methods Enzymol.
204,
125-139[Medline]
[Order article via Infotrieve]
-
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
-
Vogel, H. J.,
and Bonner, D. M.
(1956)
J. Biol. Chem.
218,
97-106[Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
-
Adler, J.
(1966)
Science
153,
708-716[Abstract/Free Full Text]
-
Chelsky, D.,
Gutterson, N. I.,
and Koshland, D. E., Jr.
(1984)
Anal. Biochem.
141,
143-148[CrossRef][Medline]
[Order article via Infotrieve]
-
Richards, F. M.
(1977)
Annu. Rev. Biophys. Bioeng.
6,
151-176[CrossRef][Medline]
[Order article via Infotrieve]
-
Bogonez, E.,
and Koshland, D. E., Jr.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4891-4895[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. M. Khursigara, X. Wu, P. Zhang, J. Lefman, and S. Subramaniam
Role of HAMP domains in chemotaxis signaling by bacterial chemoreceptors
PNAS,
October 28, 2008;
105(43):
16555 - 16560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Mazhari, C. T. Selser, and C. R. Cremo
Novel Sensors of the Regulatory Switch on the Regulatory Light Chain of Smooth Muscle Myosin
J. Biol. Chem.,
September 17, 2004;
279(38):
39905 - 39914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Homma, D. Shiomi, M. Homma, and I. Kawagishi
Attractant binding alters arrangement of chemoreceptor dimers within its cluster at a cell pole
PNAS,
March 9, 2004;
101(10):
3462 - 3467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Shiomi, M. Homma, and I. Kawagishi
Intragenic suppressors of a mutation in the aspartate chemoreceptor gene that abolishes binding of the receptor to methyltransferase
Microbiology,
October 1, 2002;
148(10):
3265 - 3275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Beel and G. L. Hazelbauer
Substitutions in the Periplasmic Domain of Low-Abundance Chemoreceptor Trg That Induce or Reduce Transmembrane Signaling: Kinase Activation and Context Effects
J. Bacteriol.,
January 15, 2001;
183(2):
671 - 679.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-I. Aizawa, C. S. Harwood, and R. J. Kadner
Signaling Components in Bacterial Locomotion and Sensory Reception
J. Bacteriol.,
March 15, 2000;
182(6):
1459 - 1471.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Umemura, Y. Matsumoto, K. Ohnishi, M. Homma, and I. Kawagishi
Sensing of Cytoplasmic pH by Bacterial Chemoreceptors Involves the Linker Region That Connects the Membrane-spanning and the Signal-modulating Helices
J. Biol. Chem.,
January 4, 2002;
277(2):
1593 - 1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|